Supply Chain

How is the business of making medicine changing in light of the COVID-19 pandemic?

How fakers are taking advantage of the pandemic.

How will the coronavirus impact manufacturing supply chains?

Could fluorescent silk proteins be the answer to the pharmaceutical industry's fake drug problem?

From improved supply chains to improved adherence, we explore how smart solutions can transform packaging – and the patient experience.

A collaboration for improved supply chain visibility.

UC Davis joins Orgenesis’ point-of-care network to develop and commercialize cell and gene therapies in house.

Only when greater transparency is established in supply chains can the industry begin to iron out problems with drug shortages.

How are digital technologies addressing supply chain challenges?

Contract laboratories need to be treated as equal partners rather than service providers.